Viewing Study NCT02219061


Ignite Creation Date: 2025-12-24 @ 1:06 PM
Ignite Modification Date: 2026-01-18 @ 8:44 PM
Study NCT ID: NCT02219061
Status: UNKNOWN
Last Update Posted: 2014-09-18
First Post: 2014-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Early Waning of Maternal Measles and Meningitis C Antibodies
Sponsor: Guangzhou Center for Disease Control and Prevention
Organization:

Study Overview

Official Title: Observation Study on Early Waning of Maternal Measles and Meningitis C Antibodies
Status: UNKNOWN
Status Verified Date: 2014-08
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: EWMM
Brief Summary: Maternal antibodies (measles and meningitis C) may wane in the first six months after birth.

* Geometric mean titers(GMTs) of measles and meningitis C.
* Follow-up on 0 month, 3rd month,5th month and 7th month after birth.
Detailed Description: Measles and meningitis C are hot topics in China in recent years. Although China had set the goal of measles elimination, many measles cases were found to be those aged \< 8 months and meningitis C is becoming public health issue since meningitis group A has been controlled at a very low level and little is known on C group. So the investigators designed the observation study on the two antibodies.

Maternal antibodies are supposed to wane after birth. Serums of the placenta(0 month), children of 3 months, 5 months and 7 months old will be collected and the geometric mean titers (GMTs) of measles and meningitis C will be confirmed by using the ELISA test.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: